Key facts
- It has raised $120K; the latest was Early Stage VC in Aug 2025.
- Notable investors include StartLife, CapitalT, Norrsken Evolve, The Biomimicry Institute.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for New Dawn Bio
- ·The full record, as it builds
Funding rounds
No funding rounds for New Dawn Bio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About New Dawn Bio
Operator of a biotechnology research firm intended to reduce the reliance on forest depletion for wood products. The company specializes in wood production through biotechnology within the climate technology and synthetic biology sectors, and also offers an alternative to traditional wood by growing wood from cells, enabling people to usher in a new era of sustainable living by improving the way they think about and create wood products.
- Sector
- Business Products and Services (B2B)
- HQ
- Wageningen, Netherlands
- Founded
- 2023
- Employees
- 5
- Website
- newdawnbio.com/
- Ownership
- Privately Held (backing)
New Dawn Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in New Dawn Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on New Dawn Bio in its N-PORT filings yet. We sweep new filings monthly.